These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 11153740)

  • 1. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy.
    Flores-Ramirez R; Lakkis NM; Middleton KJ; Killip D; Spencer WH; Nagueh SF
    J Am Coll Cardiol; 2001 Jan; 37(1):208-14. PubMed ID: 11153740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Lakkis NM; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Spencer WH
    J Am Coll Cardiol; 1999 Oct; 34(4):1123-8. PubMed ID: 10520801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Lakkis NM; He ZX; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Roberts R; Verani MS; Kleiman NS; Spencer WH
    J Am Coll Cardiol; 1998 Jul; 32(1):225-9. PubMed ID: 9669274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: short-term results in 50 consecutive procedures.
    Nielsen CD; Killip D; Spencer WH
    Clin Cardiol; 2003 Jun; 26(6):275-9. PubMed ID: 12839045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Lakkis NM; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Spencer WH
    Circulation; 1999 Jan; 99(3):344-7. PubMed ID: 9918519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy.
    Chang SM; Nagueh SF; Spencer WH; Lakkis NM
    J Am Coll Cardiol; 2003 Jul; 42(2):296-300. PubMed ID: 12875767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic left ventricular outflow and its mechanism in hypertrophic obstructive cardiomyopathy.
    Conklin HM; Huang X; Davies CH; Sahn DJ; Shively BK
    J Am Soc Echocardiogr; 2004 Apr; 17(4):375-83. PubMed ID: 15044873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiographic and clinical outcomes of patients undergoing septal myectomy plus anterior mitral leaflet extension for hypertrophic cardiomyopathy.
    Fernandez R; Nappi F; Horvath SA; Guigui SA; Mihos CG
    Rev Cardiovasc Med; 2021 Sep; 22(3):983-990. PubMed ID: 34565099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of regression of left ventricular hypertrophy following alcohol ablation of the interventricular septum in patients with hypertrophic cardiomyopathy with left ventricular outflow tract obstruction.
    Dąbrowski M; Chojnowska L; Małek L; Spiewak M; Kuśmierczyk B; Koziarek J; Klisiewicz A; Miśko J; Witkowski A
    Kardiol Pol; 2012; 70(8):782-8. PubMed ID: 22933209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of left ventricular outflow tract area on systolic outflow velocity in hypertrophic cardiomyopathy: a real-time three-dimensional echocardiographic study.
    Qin JX; Shiota T; Lever HM; Rubin DN; Bauer F; Kim YJ; Sitges M; Greenberg NL; Drinko JK; Martin M; Agler DA; Thomas JD
    J Am Coll Cardiol; 2002 Jan; 39(2):308-14. PubMed ID: 11788224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
    Mazur W; Nagueh SF; Lakkis NM; Middleton KJ; Killip D; Roberts R; Spencer WH
    Circulation; 2001 Mar; 103(11):1492-6. PubMed ID: 11257074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitral stenosis and hypertrophic obstructive cardiomyopathy: An unusual combination.
    Hong J; Schaff HV; Ommen SR; Abel MD; Dearani JA; Nishimura RA
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):1044-8. PubMed ID: 26724969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Veselka J; Honek T
    Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Ommen SR; Lakkis NM; Killip D; Zoghbi WA; Schaff HV; Danielson GK; Quiñones MA; Tajik AJ; Spencer WH
    J Am Coll Cardiol; 2001 Nov; 38(6):1701-6. PubMed ID: 11704383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Almasood A; Garceau P; Woo A; Rakowski H; Schwartz L; Overgaard CB
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1030-4. PubMed ID: 21939945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term results of alcohol septal ablation as a bail-out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification.
    Guerrero M; Wang DD; Himbert D; Urena M; Pursnani A; Kaddissi G; Iyer V; Salinger M; Chakravarty T; Greenbaum A; Makkar R; Vahanian A; Feldman T; O'Neill W
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1220-1226. PubMed ID: 28266162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Doppler echocardiographic evaluation of left ventricular diastolic function in patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation in acute and long-term follow up].
    Wojtarowicz A; Kornacewicz-Jach Z; Kaźmierczak J; Szamlewski P; Gil R; Lewandowski M
    Pol Merkur Lekarski; 2002 Jul; 13(73):25-8. PubMed ID: 12362500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-systolic drop in left ventricular ejection velocity in obstructive hypertrophic cardiomyopathy--the lobster claw abnormality.
    Sherrid MV; Gunsburg DZ; Pearle G
    J Am Soc Echocardiogr; 1997 Sep; 10(7):707-12. PubMed ID: 9339420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.